Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

31.32CNY
25 May 2017
Change (% chg)

¥-0.34 (-1.07%)
Prev Close
¥31.66
Open
¥31.58
Day's High
¥32.24
Day's Low
¥31.25
Volume
11,491,266
Avg. Vol
11,233,744
52-wk High
¥32.24
52-wk Low
¥18.25

600196.SS

Chart for 600196.SS

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.70
Market Cap(Mil.): ¥74,162.53
Shares Outstanding(Mil.): 2,414.51
Dividend: 0.35
Yield (%): 1.01

Financials

  600196.SS Industry Sector
P/E (TTM): 25.58 14.35 17.42
EPS (TTM): 1.24 -- --
ROI: 10.74 -7.29 -5.45
ROE: 14.02 -6.80 -4.73

BRIEF-Shanghai Fosun Pharmaceutical says Wu Yifang acquired 20,000 H shares of co

May 23 Shanghai Fosun Pharmaceutical (Group) Co Ltd

May 23 2017

Shanghai Fosun to offer $295 mln shares to repay debt, fund purchases

HONG KONG, May 17 Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd said it planned to sell HK$2.3 billion ($295 million) worth of new shares to repay debt, replenish working capital and to fund acquisitions.

May 16 2017

BRIEF-Shanghai Fosun Pharmaceutical enters into placing agreement to place 80.7 million H shares

May 17 Shanghai Fosun Pharmaceutical Group Co Ltd:

May 16 2017

China's Fosun Pharma launches up to $304 million share offer: IFR

HONG KONG Chinese drugmaker Shanghai Fosun Pharmaceutical launched an up to $304 million share offering in Hong Kong on Tuesday, IFR reported, citing a transaction term sheet.

May 16 2017

China's Fosun Pharma launches up to $304 mln share offer -IFR

HONG KONG, May 16 Chinese drugmaker Shanghai Fosun Pharmaceutical launched an up to $304 million share offering in Hong Kong on Tuesday, IFR reported, citing a transaction term sheet.

May 16 2017

BRIEF-Shanghai Fosun Pharma announces increase in shareholding by controlling shareholder

May 11 Shanghai Fosun Pharmaceutical Group Co Ltd

May 11 2017

BRIEF-Shanghai Fosun Pharmaceutical updates on increase in shareholding

* Co was notified by controlling shareholder, Shanghai Fosun High Technology Co Ltd that Fosun Group acquired additional A shares and H shares of co

May 09 2017

BRIEF-Shanghai Fosun Pharma's unit to invest in Partners Innovation Fund II

* Says unit signs agreement to invest $15 million in Partners Innovation Fund II L.P.

May 02 2017

BRIEF-Shanghai Fosun pharmaceutical says unit entered into JV contract

April 27 Shanghai Fosun Pharmaceutical Group Co Ltd:

Apr 27 2017

More From Around the Web

Earnings vs. Estimates